Recruiting

Dexcom

Sponsor:

Wake Forest University Health Sciences

Code:

NCT06861881

Conditions

Glucose Metabolism Disorders (Including Diabetes Mellitus)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dexcom G7 Continuous Glucose Monitor

Study Details

Brief summary:

The purpose of this research study is to test the accuracy of the Dexcom continuous glucose monitoring device during the cardiothoracic surgical procedure and recovery period in the Cardiac Intensive Care Unit. Readings from the device will be compared with the standard of care blood glucose levels that are obtained during your surgery and postoperatively.

Conditions

Glucose Metabolism Disorders (Including Diabetes Mellitus)

Study ID

NCT06861881

Start date

Nov 3, 2026

Status verified date

Nov, 2026

Completion date

Nov, 2027

Anticipated

Primary completion date

Nov, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 18 years of age or older
  • Undergoing cardiac surgery with cardiopulmonary bypass at Atrium Health Wake Forest Baptist Medical Center

Exclusion criteria:

  • Under 18 years of age
  • Pregnant women
  • Patients with a contraindication to device placement on the posterior arm, including rash, missing extremity, or existing line or device

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Device Feasibility

Interventions and Outcome Measures

Arms

experimental: Continuous Glucose Monitoring

All participants will wear the Dexcom G7 continuous glucose monitor continuously during their cardiothoracic surgery and throughout their time admitted to the Cardiovascular Intensive Care Unit.

Interventions

Dexcom G7 Continuous Glucose Monitor

Dexcom G7 continuous glucose monitor will be placed prior to cardiac surgery. It will be worn continuously throughout the perioperative period and during the time admitted to the Cardiovascular Intensive Care Unit.

Primary outcome measure

  • Continuous Glucose Monitoring Accuracy Compared to Point-of-Care Measurements [ Time Frame: Up to Day 10 ]
  • Percentage of Continuous Glucose Monitoring Accuracy with Vasopressor Use [ Time Frame: Up to Day 10 ]
  • Percentage of Continuous Glucose Monitoring Accuracy with Hypothermia [ Time Frame: Day 1 ]
  • Percentage of Continuous Glucose Monitoring Accuracy with Acidosis [ Time Frame: Up to Day 10 ]

Central Contacts and Locations

Central contacts

Megan H Hicks, MD

336-716-4498Megan.Hicks@wfusm.edu

Lynnette Harris, BSN RN

336-716-8791Lynnette.Harris@Advocatehealth.org

Locations

Wake Forest University Health Sciences

Recruiting

Winston-Salem, North Carolina, United States, 27157

Contacts

Lynnette Harris, BSN, RN

336-716-8791Lynnette.Harris@Advocatehealth.org

Megan Hicks, MD

336-716-4498megan.hicks@wfusm.edu

Principal Investigator:

Megan Hicks, MD

More Information

Sponsor

Wake Forest University Health Sciences

Last update posted

Nov 9, 2026

Last verified

Nov, 2026

Keywords

  • continuous glucose monitoring
  • cardiopulmonary bypass
  • cardiac surgery

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-10. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2026-11-09. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.